{
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": true,
    "complex_factors": [
        "Leverage",
        "Inverse Exposure",
        "Synthetic Replication via Swaps",
        "Daily Reset and Compounding Effects",
        "Counterparty Risk",
        "Complex Futures Rolling",
        "Collateralised Debt Security Structure"
    ],
    "classification": "complex",
    "supporting_data": "The WisdomTree US Treasuries 10Y 3x Daily Short is a fully collateralised Exchange Traded Product (ETP) that provides -3 times daily leveraged short exposure to the US 10-Year Treasury futures index. The product uses a fully collateralised swap structure to achieve its investment objective, explicitly referencing swap agreements and counterparty exposure. The replication method is synthetic, relying on total return swaps rather than physical holdings. The product is not UCITS compliant. It employs leverage at a ratio of -3x, with daily reset and compounding effects that can cause returns to deviate significantly from the underlying index over periods longer than one day. The product is structured as a debt security, not as an equity fund or ETF, and involves complex futures rolling strategies with front-month US Treasury futures contracts. The risk profile is at the highest level (7/7), indicating very high risk, and the documentation warns that it is intended only for informed or sophisticated investors with specific knowledge of leveraged and inverse products. The product carries significant counterparty risk mitigated by collateral held at a third party custodian, but this risk remains material. Costs include transaction costs related to futures and swaps, and the product\u2019s complexity is further increased by the daily leverage reset and compounding effects, which are difficult for retail investors to understand. The PRIIPs KID also includes comprehension warnings and highlights the need for daily monitoring and understanding of leverage and compounding risks. These factors combined meet MiFID II criteria for classification as a complex financial instrument."
}